Company Filing History:
Years Active: 1983-1984
Title: The Innovative Contributions of Catherine A. Alexander
Introduction
Catherine A. Alexander is a prominent inventor based in Indianapolis, IN (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds that serve as bronchodilators. With a total of 3 patents to her name, her work has had a meaningful impact on respiratory health.
Latest Patents
Catherine's latest patents include the innovative compounds 6-[(Cyclic amino)alkylamino]-tetrahydrotriazolo[3,4-a]phthalazines and 6-[(Cyclic amino)alkylamino]-7,8,9,10-tetrahydro-1,2,4-triazolo[3,4-a]phthalazines. These compounds are synthesized through the reaction of a 6-halo-7,8,9,10-tetrahydro-1,2,4-triazolo[3,4-a]phthalazine with an appropriate (cyclic amino)alkylamine. The resulting compounds are recognized for their utility as bronchodilators. Additionally, she has developed substituted tetrahydropyridazino-(1,6-A)benzimidazoles, such as 2-methylamino-6,7,8,9-tetrahydropyridazino[1,6-a]benzimidazole, which are also prepared by reacting a 2-halo-6,7,8,9-tetrahydropyridazino[1,6-a]benzimidazole with an appropriate amine, further emphasizing their application in respiratory treatments.
Career Highlights
Catherine A. Alexander is currently associated with The Dow Chemical Company, where she continues to innovate and contribute to the field of chemical research. Her expertise and dedication have positioned her as a key player in the development of new therapeutic agents.
Collaborations
Throughout her career, Catherine has collaborated with notable colleagues, including Norton P. Peet and Robert J. Cregge. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.
Conclusion
Catherine A. Alexander's work exemplifies the spirit of innovation in the pharmaceutical industry. Her contributions to bronchodilator compounds highlight her commitment to improving